CHRNA7 and Alzheimer disease: Considering the anti-inflammatory role of nAChR α7, α4, and β2 in the cholinergic anti-inflammatory pathway, we speculate that their elevated expression at 6 months might be an attempt to mitigate the already established pro-inflammatory profile and Aβ toxicity in the brain of our AD Tg mice75.